Patriot Financial Group Insurance Agency’s Blueprint Medicines BPMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9
Closed 597
2022
Q2
$0 Sell
9
-2
-18% -$117 ﹤0.01% 2023
2022
Q1
$1K Sell
11
-21
-66% -$1.51K ﹤0.01% 1918
2021
Q4
$3K Buy
32
+25
+357% +$2.62K ﹤0.01% 1840
2021
Q3
$1K Buy
+7
New +$652 ﹤0.01% 2028
2021
Q2
Sell
-4
Closed 2069
2021
Q1
$0 Sell
4
-14
-78% -$1.4K ﹤0.01% 1975
2020
Q4
$2K Buy
+18
New +$1.9K ﹤0.01% 1614

Other funds holding BPMC

Patriot Financial Group Insurance Agency's BPMC Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Blueprint Medicines (BPMC) in Q3 2022, closing a stake of 9 shares.

Patriot Financial Group Insurance Agency first reported a position in BPMC in Q4 2020 and held it in 6 quarters. The position peaked at $3K in Q4 2021. 240 funds tracked by Wall St. Rank hold BPMC as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Blueprint Medicines position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 9 Blueprint Medicines shares in Q3 2022.
  • Patriot Financial Group Insurance Agency first reported a position in Blueprint Medicines in Q4 2020 and held it in 6 quarters.
  • Patriot Financial Group Insurance Agency's Blueprint Medicines position peaked at $3K in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.